NYSE:WAT - Waters Stock Price, Forecast & News

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters declared that its Board of Directors has authorized a stock repurchase plan on Tuesday, April 24th 2018, which permits the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 18.2% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's management believes its stock is undervalued.

Waters Co. (NYSE:WAT) posted its quarterly earnings data on Tuesday, October, 29th. The medical instruments supplier reported $2.13 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.13. The medical instruments supplier had revenue of $577.28 million for the quarter, compared to the consensus estimate of $588.35 million. Waters had a return on equity of 77.73% and a net margin of 23.98%. The firm's revenue for the quarter was down .1% on a year-over-year basis. During the same period last year, the business earned $1.92 EPS. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Waters.

Waters will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Waters updated its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $2.95-3.05 for the period, compared to the Thomson Reuters consensus estimate of $3.23. The company issued revenue guidance of $715-729 million, compared to the consensus revenue estimate of $735.22 million.

11 brokers have issued 12-month price objectives for Waters' stock. Their forecasts range from $177.00 to $260.00. On average, they expect Waters' share price to reach $210.75 in the next twelve months. This suggests that the stock has a possible downside of 12.0%. View Analyst Price Targets for Waters.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Waters.

Media coverage about WAT stock has been trending somewhat negative this week, InfoTrie reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Waters earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Waters.

Waters saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 5,780,000 shares, an increase of 5.7% from the December 15th total of 5,470,000 shares. Based on an average daily volume of 458,500 shares, the short-interest ratio is currently 12.6 days. Currently, 9.0% of the company's stock are short sold. View Waters' Current Options Chain.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Home Depot (HD), Honeywell International (HON), Raytheon (RTN), Cisco Systems (CSCO), Procter & Gamble (PG), CVS Health (CVS), Northrop Grumman (NOC) and Verizon Communications (VZ).

Waters' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (0.45%), Fenimore Asset Management Inc. (0.18%), Independent Investors Inc. (0.07%), Copper Rock Capital Partners LLC (0.07%), American Research & Management Co. (0.06%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Edward Conard, Elizabeth B Rae, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Institutional Ownership Trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., Assenagon Asset Management S.A., Copper Rock Capital Partners LLC, Nisa Investment Advisors LLC, Boston Trust Walden Corp, State of Alaska Department of Revenue, American Research & Management Co. and Northstar Asset Management LLC. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

WAT stock was acquired by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Douglass Winthrop Advisors LLC, Diversified Trust Co and IFP Advisors Inc. View Insider Buying and Selling for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $239.60.

Waters has a market capitalization of $15.44 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

The official website for Waters is http://www.waters.com/.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]